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ABSTRACT 
Unaccustomed eccentric exercise has been well documented to elicit muscle damage 
and an inflammatory response to help fix and restore the impaired muscle fibers.  
Supplements, including anti-inflammatories and antioxidants have been used to help alleviate 
the damage and decrease the inflammation but positive results are slim.  It is proposed that 
EpiCor, a yeast metabolite with suggested anti-inflammatory and antioxidant characteristics, 
would decrease the amount of muscle soreness and inflammation that results from 
unaccustomed eccentric exercise.  
Thirty-two male subjects (ages 18-35) ingested a once daily 500mg dose of either 
EpiCor or placebo 4 weeks prior to the eccentric exercise bout.  This matched pairs, double 
blind study randomly assigned subjects to either group and were matched based on a peak, 
pre-exercise maximal isometric contraction.  Subjects then performed 50 maximal eccentric 
contractions of the elbow flexors at 30 degrees per second on each arm.  Blood samples were 
taken at pre-, 24, 48, and 72 hours post-exercise, in addition to psychological and illness 
surveys. 
 Muscle damage, soreness and circumference all had a significant effect of time 
throughout the 72 hour recovery period (P<0.001).  Elevated levels of CK and LDH were 
also present with a significant effect of time (P<0.05); however, there were no significant 
differences between treatments for muscle damage indicators.  Results for inflammatory 
markers were similar in that no statistically significant difference between groups existed for 
IL-1ra, IL-6, IL-10, and CRP, but some non-significant trends (P<.11) did exist. 
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These results do not support the hypothesized effects for EpiCor in reducing the 
muscle damage, soreness, and inflammation after an unaccustomed eccentric exercise bout of 
the elbow flexors.  This supplement needs further research into the effectiveness of its use in 
an exercise setting. 
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CHAPTER 1.  INTRODUCTION 
 Performing unaccustomed, eccentric-based muscular contractions has been well-
documented to cause muscle fiber damage that results in delayed-onset muscle soreness 
(DOMS) and inflammation (Nosaka & Newton, 2002; Croisier et al., 1996; Clarkson & 
Tremblay, 1988; Kyrolainen et al., 1998).  When a muscle is under tension and forced to 
stretch, micro-tears occur in the muscle fibers (Nosaka & Newton, 2002), which is followed 
by local inflammation (Stupka et al., 2001; Mackey et al., 2004; Lapointe et al., 2002) and 
ultimately results in a decrease of force production (Folland et al., 2001).  Sources, including 
Armstrong (1991) and Clarkson et al. (1992), have indicated that delayed onset muscle 
soreness is maximized at 48-72 hours after the eccentric bout, but researchers have not been 
able to pinpoint the exact cause for the delayed response.  After the micro-tears occur in 
muscle fibers, cell membranes are thought to be damaged, and the intracellular calcium 
homeostasis is disrupted, which leads to fiber damage and cell death (Kyrolainen et al., 1998; 
McBride et al., 1998; Beaton et al., 2002). 
As the body repairs the damage done by the first eccentric bout, it adapts from the 
previous damage in what is known as the repeated bout effect, which suggests the idea that a 
second bout of similar eccentric movements will cause less damage and stress to muscle 
fibers (Golden & Dudley, 1992; Brocket et al., 2001; Sorichter et al., 1997; Nosaka et al., 
2005; Chen & Hsieh, 2001; Lapointe et al., 2002).  Possible mechanisms behind the repeated 
bout effect include a sustained shift in the optimal contraction angle of the muscle (Brocket 
et al., 2001), repair or strengthening of various muscle components (Lapointe et al., 2002; 
Mackey et al., 2004), or a change in the neurological pathways (O‟Connor et al., 2002).  
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Researchers have investigated numerous supplements that may help protect muscles 
from the severe inflammation and soreness of an unaccustomed eccentric bout of exercise, 
including non-steroidal anti-inflammatory drugs (NSAIDS) such as ibuprofen (Hasson et al., 
1993), ketoprofen (Sayers et al., 2001), and aspirin (Francis & Hoobler, 1987), as well as 
calcium-channel blockers (Beaton et al., 2002), diclofenac sodium (O‟Grady et al., 2000), 
and antioxidants such as vitamin E (McBride et al., 1998).  Hayward et al., (1999) also 
indicated that a possible link exists between elevated protein intake and diminished markers 
of muscle damage.   
The supplement we propose to study is EpiCor, an immunogenic product based on the 
fermentation of baker‟s yeast in anaerobic conditions.  EpiCor is known to have high 
amounts of metabolites that include vitamins, polyphenols, sterols, and phospholipids.  
Additionally, Jensen et al (2007, 2008) demonstrated the components of EpiCor possess 
significant antioxidant and anti-inflammatory properties and act as an immune modulator.  
Specifically, Jensen et al., (2008) provided results of up-regulation of IL-10 production in 
EpiCor treatment groups that display anti-inflammatory aspects of the supplement.  Specific 
research with the EpiCor supplement in an exercise setting has not been performed, but with 
the suggested anti-inflammatory and anti-oxidant properties EpiCor should help reduce the 
effects of unaccustomed exercise on muscle damage and inflammation.  
Due to the suggested benefits of EpiCor supplementation, a prolonged 
supplementation of EpiCor before and during a maximum effort eccentric bout of exercise 
should significantly lower markers of inflammation and muscle damage as well as return 
muscle function to normal more quickly than with placebo.  Therefore, the purpose of this 
study is to evaluate the effectiveness of EpiCor in limiting the amount of muscle soreness, 
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inflammation, and muscle damage as well as returning normalized muscular functions within 
48-72 hours after a maximal eccentric strength training bout.  We hypothesize that the 
EpiCor supplement will reduce muscle soreness and damage after an unaccustomed bout of 
eccentric exercise and aid in a quicker recovery than a placebo.   
 
Statement of the Problem 
Does EpiCor decrease the amount of muscle soreness, inflammation, and muscle 
damage as well as return normalized muscular functions within 48-72 hours after a maximal 
eccentric strength training bout? 
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CHAPTER 2.  REVIEW OF LITERATURE 
 
Muscle Damage 
 
 One of the first studies of exercise-induced muscle damage came from Hough in 
1902, who suggested that delayed muscle soreness was a result of micro-tears in the muscle 
fibers.  Almost 80 years later, Friden et al. (1981) provided some of the first evidence of 
exercise-induced muscle damage through biopsies of soleus muscle tissue taken two and 
seven days after exercise.  Major findings in this study were myofibrillar disturbances and z-
line streaming.  Friden and others (1983) continued to research this phenomenon and 
discovered many observed ultrastructural changes after eccentric exercise, which included z-
line streaming and z-lines out of register, loss in thick myofilaments, loss in mitochondria in 
areas of abnormalities, and disturbed arrangement of A-band filaments.  These findings have 
been supported by many other research studies over the last 30 years, including Armstrong et 
al. (1983), Newham et al. (1986), Schwane et al. (1983), and Stupka et al. (2001).  This 
research provides support for the notion that exercise stresses skeletal muscle fibers and that 
if the intensity or duration provides a tensile strength stimulus greater than that of the muscle 
yield strength, damage to the muscle fibers occurs. 
Since a definite pathway for injury has not been established, a possible sequence of 
events that describe muscular damage after exercise was proposed by Morgan (1990).  
Lengthening of the active muscle, or eccentric exercise, causes some sarcomeres in each 
myofibril to extend to long lengths from which some do not fully return to the interdigitating 
pattern on relaxation.  The repeated stretch-contraction would quickly stretch those 
sarcomeres and place extra tension on neighboring myofibrils at those sarcomeres, which 
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results in sarcomere tears.  If sufficient tearing occurs, the sarcoplasmic reticulum or 
sarcolemma can become damaged, which leads to intracellular calcium release, contractures, 
clots, and eventual destruction of the fiber in days following exercise (Morgan, 1990).   
Contraction properties of fibers have also played a role in determining which fiber 
type is more prone to exercise injury and what speeds elicit the most exercise-induced muscle 
damage.  Jones et al. (1986) provided data that type II muscle fibers are more severely 
affected than type I fibers by eccentric exercise, specifically in the severely affected calf 
muscles of this study.  It is now understood that because type II muscle fibers are the 
narrowest fiber type and contain the weakest z-lines, they are more susceptible to damage.  
Results from Friden et al. (1983) provided additional evidence when they recorded that z-
band streaming and broadening occurred more in type II than type I muscle fibers.  A 
concurrent decrease in force output during maximal knee extension exercises was seen, an 
expected result if type II motor units were damaged.  Similar results were observed in 
eccentric exercise of the elbow flexors (Gibala et al. 1995).  A study in 2005 by Paddon-
Jones et al. examined different expressions of muscle damage following fast or slow velocity 
eccentric exercise and discovered that fast eccentric contractions resulted in a longer period 
of muscle soreness, whereas slow eccentric contractions were associated with a greater 
increase in swelling and greater decrease in the ability to generate torque. 
Indicators of Muscle Damage 
  Creatine Kinase (CK) 
 Researchers have generally accepted CK as a primary, indirect indicator for muscle 
damage because the enzyme is mostly found in muscle tissue.  The release of CK into serum 
or plasma is a result of membrane disruption from exercise, most notably eccentric exercise 
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as shown by Newham et al. (1983) and Miles et al. (2008).  Studies have been performed to 
examine the CK release rate, and results show that modes of exercise that include eccentric 
running (Armstrong et al., 1983) and isometric exercises elicit a larger initial CK response 
that returns to normal within a few days.  Local eccentric muscular exercises, however, cause 
a much larger CK response that does not begin until two to three days after exercise with a 
peak at four to six days (Jones et al., 1986).   
The size and timeline of the CK release is dependent upon the type, intensity, and 
duration of eccentric exercise. Nosaka et al. (2002) showed that through 12 maximum 
eccentric exercises compared to two hours of concentric submaximal exercises 
(approximately 3600 contractions) there was a delayed but sustained elevation in indirect 
muscle damage markers in maximal compared to submaximal exercise. Chen et al. (2007) 
provide evidence that eccentric exercise at 100% intensity results in a much larger CK 
response than exercise at 40, 60, and 80% intensity.  Results from Brown et al. (1997) 
showed that subjects displayed muscle damage with 30 and 50 repetitions, but the 10 
repetition group showed no significant CK increase.  The latter group, however, did have a 
decrease in force generation, which suggests that force loss and elevated CK levels are not 
related.  It is possible that 10 reps was not a great enough stimulus to elicit damage to 
susceptible fibers but, as previously mentioned, statistically significant muscle damage was 
present after 8 repetitions (Warren et al., 1993).  The magnitude of the CK response is highly 
variable. Newham et al. (1983) discovered that, during stepping exercises, participants all 
showed an early rise in CK (<400IU/L) but half of subjects, both male and female, showed 
levels up to 34,500 IU/L and took four to five days to reach peak levels.   
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Lactate Dehydrogenase (LDH) 
Lactate dehydrogenase (LDH) is an enzyme used in the glycolytic energy pathway in 
the production of ATP and has been considered an indicator of tissue breakdown (Mikkelsen 
et al., 2004).  In terms of eccentric exercise, LDH has been used as an indirect indicator of 
muscle damage whether using endurance exercise (Armstrong et al., 1983) or eccentric 
muscle contractions (Costa et al., 2007, Lowe et al., 1995, Brown et al., 1997).   
The exercise stimulus does have an influence on the release timeline post-exercise 
with eccentric exercise as seen in Armstrong et al. (1983).  Researchers found that all 
exercise protocols resulted in elevated LDH immediately after running, but only eccentric 
exercise resulted in a delayed elevation approximately two days post-exericise.  Other studies 
have shown significant increases in LDH post-exercise lasting up to 72 (Brown et al., 1997, 
1999) and 96 hours (Milias et al., 2005).  In addition to the type, the muscle group used has 
been shown to have an effect on the size of the LDH release.  Jamurtas et al. (2005) provided 
results directly comparing elbow flexors and knee extensors in the same subjects with the 
same workload intensity that saw a significant LDH increase from 24-96 hours post-exercise 
in the elbow flexors but not in the knee extensors. 
 The above research indicates that LDH is an indirect indicator of muscle 
damage but can not alone provide quality results for muscle damage as LDH is an indicator 
of tissue breakdown in general; however, when elevations in LDH are also shown with CK, 
another accepted indirect indicator of muscle damage, the applicability of the results 
increases (Costa et al., 2007, Brown et al., 1997, Milias et al., 2005). 
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Eccentric versus Concentric Exercise as Cause of Exercise-Induced Muscle 
Damage 
 
 Research has shown that eccentric exercise is a primary stimulus for causing muscle 
damage during exercise, which results in soreness, reduced muscle function, inflammation, 
and a decreased range of motion.   
When comparing eccentric to concentric muscle action as a mode for muscle damage, 
research generally shows that eccentric exercise causes more muscle fiber damage than 
concentric exercise.  Armstrong et al. (1983) directly compared eccentric to concentric 
exercise through downhill (eccentric) or uphill (concentric) running with mice at a 16
o
 slope.  
The researchers found that all exercise protocols, including uphill running, resulted in 
elevations of plasma enzymes immediately after running; however, only eccentric exercise 
resulted in late phase elevations 1.5-2 days post-exercise.  Additional findings from the study 
indicate that eccentric exercise produces more muscle fiber damage than concentric exercise 
of equal power.  Since then, further research has been performed with humans, looking at 
downhill versus uphill exercise with similar results that suggest eccentric exercise (downhill) 
causes more damage to muscle fibers for a longer duration than concentric exercise (uphill).  
Newham et al. (1986) used indirect measures of muscle damage and discovered that eccentric 
exercise was responsible for significantly increased and delayed plasma CK release, as also 
seen by  Balnave et al. (1993).  Lynn and Morgan (1994) added to the discussion that, 
through the adaptable capacity of muscle, examining the fiber lengths and sarcomere 
numbers after exercise can also be an indicator for muscle damage.  The researchers 
discovered that eccentrically exercised muscle fibers contained a higher number of 
sarcomeres per muscle fiber compared to concentrically exercised muscle fibers, which 
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indicate that an adaptation occurred.  Research from Macpherson et al. (1997) provided 
evidence of a 9-11% force deficit in stretched muscle fibers, and a majority of the damage 
was focused in the areas with the longest sarcomeres.  More support is provided by Child et 
al. (1998), whose subjects performed eccentric exercises at two different knee extensor 
muscle lengths, 160-80
  
degrees and 120-40
 
degrees, with results indicating that greater 
muscle damage occurred after the long muscle lengths protocol (120-40
o
).   
Apart from downhill running, there are other forms of eccentric exercise, most 
notably through maximal force generation.  Friden and others (1986) discovered that muscles 
concentrically contracting resulted in less accumulation of intramuscular pressure than those 
muscles that are stretched while contracted.  Later, Jones et al. (1989) showed that eccentric 
exercise resulted in more muscle damage, greater fatigue, and greater delayed onset of pain 
than concentric or isometric muscle actions, also seen by Croisier et al. (1996).  A study 
conducted by Warren et al. (1993) showed that decreases in maximal isometric strength and 
muscle function did not result from the first eccentric movement but rather eight repetitions 
was the beginning of statistical significance.   
Gibala et al. (1995) had each subject perform concentric contractions with one arm 
and eccentric contractions with the other arm and examined the differences in muscle 
damage.  Not only were there significant decreases in isometric peak torque for the 
eccentrically exercised elbow flexors, but approximately 80 % of the total muscle fibers 
displayed some type of disruption.  Nosaka & Newton (2002) also provided evidence that, at 
an absolute workload equal to 50% of the maximal isometric force of elbow flexors, the 
eccentric exercise elicited greater muscle damage than concentric exercise.  The researchers 
did note that eccentrically contracted muscles require less energy to contract, yet elicited the 
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most damage; however, it is known that eccentrically contracted muscles can generate more 
force than isometric or concentric contractions, which could suggest that eccentric 
contractions should show less damage than concentric or isometric contractions.  
Knee Extensors versus Elbow Flexors to Elicit Muscle Damage 
  
 When it comes to muscle isolation exercises to elicit muscle damage through 
eccentric contractions, the two main groups of muscles utilized are knee extensors (Hasson et 
al., 1993, Brown et al., 1997, Sorichter et al., 1997, Child et al., 1998) and elbow flexors 
(Newham et al., 1987, Nosaka & Clarkson, 1996, Chen et al., 2001, 2007, Lavender et al., 
2008).  Based on information presented above about muscle fiber type, it is known that type 
II fibers are less resistant to exercise-induced muscle damage, so isolating muscles with a 
higher distribution of type II fibers would be ideal.  Klein et al. (2003) provided evidence 
through magnetic resonance imaging that the biceps brachii were composed of 61.5% type II 
fibers in young men while Travnik et al. (1995) showed a higher type I fiber distribution in 
knee extensors, specifically the vastus medialis longus and vastus medialis obliquus; 
however, none of these studies compared knee extensors and elbow flexors in the same 
subjects, and it is possible that similar fiber distributions exist in all muscle groups for any 
given subject.  
It was not until 2005 that Jamurtas et al. compared elbow flexors and knee extensors 
during eccentric exercise to see which muscle group elicited the greatest damage from the 
same relative intensities in the same subject.  Researchers used data that included maximum 
eccentric and isometric peak torques, range of motion, delayed onset muscle soreness, and 
indirect blood markers of muscle damage including CK, LDH, and myoglobin (Mb) to view 
the differences between 6 sets of 12 repetitions at 75% maximal eccentric peak torque in 
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each muscle group.  The results provided evidence that the elbow flexors induced a larger 
decrease and slower recovery in strength and a larger increase in the blood markers of muscle 
damage than knee extensors.  These findings were later verified in 2009 when Saka et al. 
provided additional evidence that greater muscle damage and a slower recovery occurred 
with elbow flexors than knee extensors.       
 
Inflammatory Response 
 
 Research has concluded that exercise-induced muscle injury occurs following 
eccentric exercise.  When the muscle damage occurs, typically there is capillary rupture, 
which sends blood-borne inflammatory cells and cytokines directly to the damage.  The size 
of the inflammatory response depends on the size of the muscle injury and the amount of 
vascularization at the injury site (Tidball, 2005, and Merrick, 2002).  This rapid inflow of 
inflammatory cells can last from several days to several weeks with the primary purpose to 
promote the clearance of damaged tissue and prepare the tissue for repair (MacIntyre et al., 
1995).   
Trigger of Inflammatory Response 
No one has been able to pinpoint the exact trigger of the inflammatory response 
following exercise-induced muscle damage.  Researchers have suggested the release of 
prostaglandins (PG)  as one of the main causes of the inflammatory response.  These are 
produced from local inflammatory cells that are in the damaged area, which then leads to the 
recruitment of other inflammatory cells (Issekutz and Movat, 1982).  Other research suggests 
that potentially humoral and cardiovascular factors, more than muscle damage via exercise 
(Brenner et al., 1999), and yet Blais et al. (1999) provided evidence that bradykinin release 
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could mediate the inflammatory response.  Cytokines have also been considered as the 
trigger for the inflammatory process (Pedersen et al., 1998).  This conflicting evidence 
provides support that the events that lead to the inflammatory response as a result of muscle 
damage is quite complex; however, we can speculate that since the innate inflammatory 
response is activated by damaged cells and tissues, not just infectious material, the exercise-
induced muscle damage is enough to trigger the inflammatory response. 
Role of Cytokines 
One of the more researched chemotactic substances released during the inflammatory 
process is cytokines, as Cannon and St. Pierre (1998) indicated that almost all cells with 
nuclei synthesize cytokines and have cytokine receptors on their cellular membranes.  When 
cells such as vascular endothelium are stimulated, they release cytokines which, in turn, 
regulate the release of adhesion molecules that attract neutrophils.  Milias et al. (2005) 
suggested that leukocytosis is an indicator of muscle damage after endurance exercise as a 
positive correlation between leukocyte numbers and plasma CK levels existed, with similar 
positive correlations between leukocyte response, CK, and LDH reported by Kayashima et 
al. (1995) after strenuous exercise.  Additionally, significant correlations between delayed 
leukocytosis and indices of muscle damage suggest that exercised muscles generate the 
inflammatory mediators that result in the increased release of leukocytes (Paulsen et al., 
2005). 
Generally, the inflammatory response after tissue injury results in early release of 
cytokines IL-1β and TNFα (Miles et al., 2008).  Ostrowski et al. (1999) showed that, with 
strenuous exercise, TNFα and IL-1β levels are substantially increased during the examined 
four-hour period post-exercise.  These researchers also suggested that cytokine inhibitors and 
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anti-inflammatory cytokines (IL-1ra, sTNF-r1 and sTNF-r2) restrict the magnitude and 
duration of the inflammatory response to exercise.  These factors, such as interleukins (IL-), 
are thought to initiate the onset of circulating neutrophils into the muscle tissue.  Many 
studies have provided results that specify whether certain cytokines are related to exercise-
induced muscle damage or if specific cytokines control the release of other cytokines.  
Typically, research has shown that endurance exercise (Brenner et al., 1999, Ostrowski et al., 
1999, Suzuki et al., 2003, Nieman et al., 2005) is a better cytokine stimulant than eccentric 
exercise. Additionally, Louis et al. (2007) present evidence that up-regulation of specific 
mRNA resulted from a cardiovascular run at 75% for 30 minutes compared to 30 repetitions 
of concentric knee extension at 70% of a 1-repetition maximum.  These findings could be 
explained by a greater overall muscular stress in the endurance events or by a diminished 
cytokine disposal into the systemic circulation and ultimately into the urine during endurance 
exercise.  During endurance exercise, blood flow through the renal system is significantly 
reduced when compared to exercise of specific muscle groups (e.g., elbow flexors).  This 
decrease in renal function could lead to a slower clearance of cytokines (Hirose et al., 2004).  
For the purposes of the present study, the influx of IL-1 receptor antagonist(ra), IL-6, and IL-
10 will be examined in response to exercise.  In addition to these cytokines, C-reactive 
protein (CRP) will be analyzed after unaccustomed eccentric exercise. 
IL-1(ra) 
 IL-1(ra) is an antagonistic inhibitor of IL-1, an important pro-inflammatory cytokine 
in the immune response, binding to the receptor and preventing the actions of IL-1 
(Ostrowski et al., 1999).  Typically, research has shown greater release of IL-1ra after 
endurance exercise, and the release after eccentric exercise is quite minimal.  Nosaka & 
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Clarkson (1996), however, did not report any increase in IL-1(ra) after local muscular 
eccentric exercise in the elbow flexors, possibly due to a smaller muscle mass used during 
the eccentric training protocol.  
IL-6  
IL-6 has been discussed as a main regulatory cytokine in the inflammatory response, 
as it has been shown to have both pro- and anti-inflammatory properties (Bruunsgaard et al. 
1997).  Tomiya et al. (2004) have specifically indicated IL-6 is a cytokine that is observed in 
myofibers after eccentric exercise and preceding myofiber disruption, suggesting that IL-6 is 
active in the muscle degeneration process after muscle injury.  Other researchers agree with 
Tomiya et al. and provide evidence that IL-6 is a sensitive marker of acute inflammation and 
one of the first responses following eccentric exercise.  MacIntyre et al. (2001) and 
Willoughby et al. (2003) showed that a peak saturation of IL-6 occurred approximately six 
hours after exercise and that early increases in IL-6 predicted a component of delayed onset 
muscle soreness.  Miles et al. (2008) viewed peak levels of plasma IL-6 approximately eight 
hours after exercise, and Tomiya et al. (2004) presented peak levels between eight and 12 
hours; but all levels have been shown to return to baseline approximately 24 hours post-
exercise.  These results show IL-6 as a pro-inflammatory cytokine, which suggests that 
elevated plasma levels of IL-6 can be an indication of the amount of inflammation occurring 
in the damaged tissue.  Nieman et al. (2005) presented a statistically significant correlation 
between IL-6 (125x increase between pre- and post-race) and CK after a 160km run, which 
suggests that IL-6 is released as a part of the response to muscle damage.   
 
IL-10 
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 IL-10 is an anti-inflammatory cytokine with a main function of suppressing pro-
inflammatory cytokines such as TNF-alpha, Il-1, IL-6 and IL-8 (Hirose et al., 2004).  
Released after strenuous exercise, IL-10 has also been shown to govern the release of IL-1ra, 
a known inhibitor of the pro-inflammatory cytokine IL-1 (Cassatella et al., 1994, Jenkins et 
al., 1994).  Ostrowski et al. (1999) also showed that IL-10 plays a role in the release of IL-
1ra, as high levels of IL-10 were present immediately after a marathon and subsequently 
decreased as IL-1ra levels had a significant increase.  Smith et al. (2000) showed a 
significant increase in IL-10 between 48 and 144 hours post-eccentric exercise, findings 
consistent with results provided by Silva et al. (2008).  Il-10 has been a prime anti-
inflammatory cytokine in past research which provides reason to examine the changes in IL-
10 in the present study. 
CRP 
 C-reactive protein (CRP) is another generally accepted marker of inflammation and is 
made by the liver in response to elevated plasma levels of IL-6 in the body (Phillips et al., 
2003).   Subjects in this study also displayed a decrease in CRP after eccentric exercise with 
the combined use of tocopherols, docosahexaenoate, and flavonoids.  Milias et al. (2005) 
found no increase in CRP after eccentric exercise of the elbow flexors, even with significant 
increases in muscle damage indicators, with similar results in Nosaka & Clarkson (1996).  
Malm et al. (2000) did see an increase in CRP following exhaustive eccentric cycling, which 
has more of an endurance component than the exercise protocol of Milias et al. (2005) or 
Nosaka & Clarkson (1996), but the increase was not significant when compared to the 
control group or rest.  On the other hand, Paulsen et al. (2005) showed a statistically 
significant increase in plasma CRP after 300 maximal eccentric contractions of the 
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quadriceps both at 24 and 48 hours after exercise.  These mixed results indicate that more 
research is needed to fully understand the effects of the plasma CRP response after eccentric 
exercise.   
 
Cellular Response 
Previous research has not narrowed down the exact mechanism for how muscle tissue 
damage, potentially caused by eccentric exercise, elicits the innate immune response; 
however, research shows that, after muscle damage occurs, one of the first inflammatory 
cells that reach the damaged muscle are neutrophils.  This influx can begin within one hour 
of exercise, and amounts can remain elevated as long as five days (Fielding et al., 1993).  
The increased concentrations of neutrophils in the damaged area are indicators of muscle 
damage and release proteolytic enzymes (proteases) that break down and dissolve the injured 
muscle tissue and cells. Both Nguyen and Tidball (2003) and Tiidus (1998), on the other 
hand, suggest that neutrophils can release high concentrations of cytolytic and cytotoxic 
molecules, including reactive oxygen species, that are capable of damaging surrounding 
muscle tissue, which exacerbates the already present damage.  Brickson and others (2003) 
indicated that, through the use of antibodies that block a specific reactive oxygen species, 
less muscle damage occurred.  Other research, including Lowe et al. (1995), provided 
evidence that the rate of protein degradation was not enhanced through the presence of 
excessive neutrophils when compared with normal levels of neutrophils.  Differences did 
exist in the training protocols of each study as subjects in the Brickson study only performed 
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a single eccentric contraction to elicit muscular tissue damage while Lowe had subjects 
perform 150 eccentric contractions.  
 After the first response of neutrophils begins to subside, macrophages begin to 
migrate towards the damaged tissue area approximately 8-12 hours after exercise has ceased.  
Macrophages have been shown to be detrimental to the recovery process (Lapoint et al., 
2002) as they elicit extensive damage after the initial injury occurs through a nitric oxide-
dependent lysis of muscle cell membranes (Nguyen and Tidball, 2003).  On the other hand, 
research has also shown that reducing the macrophage concentration does prolong the 
recovery time and other evidence has been presented that macrophages aid in the recovery 
process (Chazaud et al., 2003).  The general consensus is that neutrophils and macrophages 
make up a significant portion of the inflammatory response; however, the exact contribution 
from neutrophils, macrophage, and other inflammatory cells is unknown, and the 
contributions from each during the inflammatory response is quite complex.   
The sensation of pain or soreness 24-48 hours post-exercise is a phenomenon called 
delayed-onset muscle soreness (DOMS).  During the inflammatory response, the neutrophils 
and macrophages release bi-products that have been theorized to sensitize muscle afferent 
nerve fibers, but no one bi-product has been established as the main cause of pain.  
Prostaglandins have received much attention as the trigger for the pain response, but research 
is mixed.  Uchida et al. (1999) showed a weak but significant correlation between peak 
soreness and PG concentration, and Schwane et al. (1983) suggest that PGs, specifically 
PGE2 , sensitizes the type III and IV pain fibers.  Conflicting evidence is presented by 
Kuipers et al. (1985) and Croisier et al. (1996) as PGs were not directly related to muscle 
soreness.  Bradykinins have also been hypothesized as a mediator of the pain response (Blais 
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et al., 1999 and Murase et al., 2010), but no undisputable evidence is present to support these 
hypotheses.   Free radicals, produced by both neutrophils and macrophages (Nguyen and 
Tidball, 2003; Malm et al., 1999) have also been examined as the initiator of DOMS.  Like 
PGs and bradykinins, evidence has been mixed, but evidence has been presented for 
(Maughan et al., 1989) and against (Close et al., 2004) free-radicals as the trigger for the pain 
response.  It could be hypothesized that a combination of the above-mentioned substances 
interacts in ways not currently understood to create a combined pain response, but further 
research is needed to understand this phenomenon. 
 
Muscle Tissue Recovery 
 
 After the initial exercise bout elicited damage to muscle tissue, researchers have 
discovered that a training effect occurs and provides a „protective effect‟, which is described 
as a decrease in muscle damage after a subsequent exercise bout of the same nature.  Current 
research has not established a definitive process through which muscle tissue returns to 
normal nor an adequate timeline for the process, but many theories do exist.  Howell et al. 
(1993) provided evidence that supports total regeneration of muscle strength following an 
initial bout of exercise-induced damage that lasted up to 12 weeks.  At the end of day 10, 
muscle had only recovered approximately 70%, and measurements performed by the 
researchers during weeks five and six post-exercise suggested that the half-life for muscle 
strength recovery could be up to five weeks.  Others, including Chleboun et al. (1998) 
reported results that indicated a gradual return of muscular strength 11 days after initial 
exercise.  Clearly, with such a wide discrepancy as to the return to normal force generation 
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and protocols that range in duration, intensity, and muscles worked, more research is needed 
to continue to discover the underlying cause and timeline of muscle tissue recovery. 
One suggested adaptation is a shift in the length-tension relation, which provides a 
new optimal angle of contraction. Chen et al. (2007) showed that a significant shift in the 
optimal angle was evident two to three weeks after the initial maximal eccentric exercise 
bout in the elbow flexors, with the suggested explanation that the exercise stimulus used 
induced greater muscle damage when compared to others who show a smaller duration for 
the change in optimal angle.  Brockett et al. (2001) went even further and offered a 
hypothesis that suggests there are two shifts in length-tension relation.  The first shift is a 
direct result of disruption of sarcomeres in muscle fibers and was evident immediately after 
exercise but only lasted for a day or two. The second shift involves the development of a 
more sustained shift in length-tension relation (7.7
o
 ± 2.1
 o
 shift) (P<0.01), which represented 
a training effect in the muscle. 
 
Repeated Bout Effect 
 
Significant amounts of literature exist that suggest a repeated bout effect is a part of 
the adaptation of muscle tissue following an unaccustomed bout of exercise.  There is 
confusion, however, as to the length of the repeated bout effect or “protective effect,” which 
some studies have shown to be dependent upon the intensity of the original bout of exercise.  
Byrnes et al. (1985) examined repeated bouts of downhill running in different time 
increments, including three, six, and nine weeks apart with the same exercise protocol.  The 
researchers found significantly lower levels of CK, myoglobin, and perceived muscle 
soreness between bouts performed three and six weeks apart but approached baseline levels 
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after nine weeks.  Also, they discovered that patterns of response were similar between bout 
1 and 2, suggesting that the mechanisms responsible for soreness and enzyme release are the 
same but that differences exist in the magnitude brought on by the first bout.  Additionally, 
Balnave and Thompson (1993) had subjects perform downhill walking once a week for eight 
weeks with a 25% grade at 6.4km/hr and found that muscle soreness and indicators of muscle 
damage saw significant increases during the first week with subsequent decreases each week 
thereafter.  
Looking at maximal eccentric contractions, Clarkson and Tremblay (1988) compared 
70 and 24 maximum eccentric contractions in different arms of the same subjects and 
provided results suggesting that an adaptation takes place such that the muscle can lower 
more weight during repeated exercise.  The results also showed that muscle is more resilient 
to exercise-induced muscle damage through the significantly lower indicators of damage, and 
any damage that does occur can be repaired at a faster rate due to a suggested strengthening 
of the surrounding connective tissue or membrane hypothesis.  Newham et al. (1987) and 
Brockett et al. (2001) found similar results but offered a hypothesis that force loss was a 
result of changed contractile elements, which lends support to a possible removal of stress-
susceptible fibers as the protective effect.  Brown et al. (1997) looked at differing numbers of 
repetitions (10, 30, or 50) followed by 50 three weeks later and found increases in muscle 
soreness, force, and CK  in the 30 and 50 repetition groups, followed by less or no increase 
after the second bout of 50 eccentric exercises.  This showed that skeletal muscle changes 
can be elicited by relatively few contractions, but increasing repetitions did not result in an 
increased prophylactic effect.   
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There is also evidence that the intensity of the exercise or length of muscle during 
contraction plays a role in the magnitude of the repeated bout effect.  Chen et al. (2007) 
provided evidence that the larger the intensity of eccentric bout 1, the greater the magnitude 
of the protective effect and even showed protective effect at 40% intensity.  Nosaka and 
Clarkson (1995) looked at repeated bout effect of short and long eccentric contractions and 
showed that the magnitude of eccentric exercise-induced muscle damage is dependent on the 
muscle length, such that eccentric exercise at long lengths induces greater muscle damage 
than at short lengths. 
 
Nutritional Supplements 
  
Carbohydrates 
 
 Studies have shown that the effect of altered carbohydrate levels on exercise-induced 
muscle damage has yet to be established.  Close et al. (2005) discovered that, despite altered 
carbohydrate levels for two days prior to eccentric exercise, there was no effect on the loss or 
recovery of muscle function, delayed-onset muscle soreness, or the production of reactive 
oxygen species.  The study was performed under the assumption that the previously 
mentioned effects of eccentric exercise were possibly caused by invading phagocytes into 
muscle tissue, which depends on plasma glucose levels.   
 
Protein 
 
 In a study that examined the effect of dietary protein levels on enzyme activities after 
eccentric exercise in mice, researchers discovered that a high protein diet (50% of calories) 
resulted in higher levels of CK and AST when compared to a normal or low protein diet, 
12% and 4% calories from protein respectively.  Protein content in this diet was primarily 
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from casein protein.  The researchers suggested the additional amounts of protein in a high 
protein diet were a primary cause of the increased amounts of enzyme expression after 
exercise due to the highly controlled diet and exact exercise protocol between subjects.  
There is some confusion as to the mechanism behind the additional enzyme expression; some 
research points towards an increase in the enzyme synthesis or an increase in the absolute 
amounts of enzyme mRNA levels, but generally research shows that the effects of dietary 
protein must be considered in the context of exercise-induced muscle injury.   
  
Combined CHO and Protein 
 
 The combined effects of carbohydrates and proteins in a supplement have been shown 
to attenuate exercise-induced muscle damage more than carbohydrates and proteins 
individually.  Baty et al. (2007) showed that a combined CHO-protein supplement appeared 
to reduce muscle damage via reductions in myoglobin and CK when compared to placebo, 
and Bird et al. (2006) demonstrated a reduction in cortisol and 3-methyl-histodine levels, 
which suppressed protein degradation through a supplementation of liquid carbohydrates and 
essential amino acids.  Additionally, Cockburn et al. (2008) indicated that milk and milk-
based protein-carbohydrate supplementation resulted in a smaller influx of plasma CK and 
myoglobin. 
Cherry Juice 
 Research has looked at many other food and plant extracts in reducing the muscle 
damage and inflammatory response after eccentric exercise.  Connolly et al. (2006) evaluated 
the effectiveness of a fresh tart cherry juice in reducing the effects of eccentrically induced 
muscle damage.  Tart cherries contain flavonoids and anthocynanins that have high anti-
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oxidant and anti-inflammatory properties that inhibit the effects of cyclo-oxygenase produce 
biological mediators that cause inflammation and pain (Wang et al., 1999).  Subjects in 
Connolly‟s study reported significantly less strength loss when supplemented with tart cherry 
juice compared to placebo, four percent compared to twenty-two percent, respectively.   
  Allicin 
Allicin, a compound that results from crushing garlic, has been supplemented to 
reduce muscle damage that results from eccentric exercise.  Amagase et al. (2001) suggested 
that, depending on its ingested form, garlic can have immune-enhancing or anti-oxidative 
capacities that typically result from many different biologically active compounds.  It is 
suggested that allicin is the compound most responsible for garlic‟s biological activity and is 
typically the most researched garlic compound.  Su et al. (2008) suggested that the anti-
inflammatory and anti-oxidative capacities of allicin would decrease the inflammatory 
response and muscle damage after eccentric exercise.  Subjects were required to run downhill 
on a treadmill to elicit the muscle damage, to which allicin supplemented subjects had a 
diminished release of CK, LDH, IL-6 compared to placebo subjects.  Additionally, subjects 
in the allicin group reported a decrease in soreness after the exercise bout. 
  Honokiol 
Other research has utilized honokiol, a bioactive component of the Chinese herb 
Magnolia officinalis, to reduce the effects of unaccustomed eccentric exercise (Chiang et al., 
2009).  Honokiol, known for its potential anti-inflammatory and anti-oxidant properties, was 
supplemented in the form of a 1mg dose for 5 days prior to exercise or one 5mg dose one 
hour before exercise.  Researchers discovered that honokiol supplemented mice showed 
significantly less muscle damage compared to the placebo group.  Chiang suggested that 
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honokiol suppressed both the COX-2 enzyme expression and pro-inflammatory cytokines, 
both of which decrease the inflammatory response.  
 
 
 Curcumin 
 Curcumin is a constituent of turmeric and has been evaluated by Davis et al. (2007) 
for its effect at reducing exercise induced muscle damage.  Previous research has indicated 
turmeric has anti-inflammatory properties that reduce the activation of COX-2 and remove 
free radicals (Huang et al., 1991, Kang et al., 2004).  Davis and others provided results of a 
decreased CK and inflammatory cytokine concentrations (Il-6, TNF-alpha, IL-beta) in rats 
supplemented with curcumin compared to placebo. 
Supplementation 
The effect of anti-inflammatory drugs on exercise-induced muscle injury has been 
researched with mixed findings.  When the inflammation response is triggered, as it is via 
exercise-induced muscle damage, prostaglandins and prostacyclin are both generated in the 
arachidonic acid pathway via the cyclo-oxygenase (COX) enzyme.  The production of 
prostaglandins, or PGE2, sensitizes the type III and IV pain afferents that are now responsive 
to chemicals like bradykinns and result in the muscle soreness. The basis for why anti-
inflammatory drugs work follows. 
Aspirin 
  
 In a study conducted by Francis and Hoobler (1987), the effect of aspirin was 
examined following extensive muscle-damage induced by eccentric exercise.  Along with 
another study by Ferreira et al. (1973), this study provided evidence that aspirin does not 
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eliminate hyperalgesia but rather nullifies the potentiating effect produced by prostaglandins 
via inhibiting prostaglandin synthesis.  Also, these studies provided evidence that aspirin 
does not improve muscular function, which shows that muscle injury occurred with and 
without aspirin. 
 
NSAIDs 
 
There are two distinct inconsistencies among studies that evaluate the effectiveness of 
NSAIDs at reducing the effects of unaccustomed, eccentric exercise on muscle tissue: timing 
of drug administration and the dose of drug administration.  Ibuprofen is a well-known anti-
inflammatory and has been studied for its effects in reducing exercise-induced muscle 
damage and soreness.  Hasson et al. (1993) evaluated the effect of prophylactic versus 
therapeutic administration of ibuprofen on muscle soreness, damage, and performance 
through equal 400 mg doses at four hours before exercise or 24 hours after baseline.  Results 
indicated that the prophylactic group reported 40-50% less soreness in addition to 
demonstrating a smaller decline in maximal muscle torque generated at 24 hours post-
exercise but did not reduce CK levels.  Tokmakidis et al. (2003) did observe that six 400 mg 
doses of ibuprofen during the 48 hours post-exercise resulted in a significant decrease in CK 
levels when compared to the placebo group, whereas Rahnama et al. (2005) observed no CK 
or pain decrease with a similar dosing regimen.  Tokmakidis et al. (2003), however, 
generated a very small CK response (~200IU) from the exercise.  Gulick et al. (1996) used a 
much larger dose (1800 mg) of ibuprofen as the load dose and followed with 1200 mg 
oxaprozin after the exercise-induced damage with no decrease in DOMS symptoms.  
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Other NSAIDS have been studied, including ketoprofen and diclofenac sodium.   
Sayers et al. (2001) performed a study with the use of ketoprofen, a NSAID like ibuprofen 
but with additional pathways of action.  In this study, subjects experienced adequate muscle 
damage and were instructed to take a therapeutic dose of either 0, 25, or 100mg 36 hours 
after the exercise bout and continue taking the same dose each hour for eight hours total.  
Results showed that subjects who ingested ketoprofen showed a significantly lower 
perception of soreness and an increased ability to generate muscle force when compared to 
the placebo group.  Further analysis showed that maximal EMG activity did not change with 
supplementation and provided evidence that the increased force capacity is from a reduced 
inflammatory response and not enhanced motor unit activation. Where NSAIDs have been 
shown to inhibit primarily the cyclo-oxygenase (COX) pathway, ketoprofen also inhibits the 
lipoxygenase (LIPOX) pathways and had activity at both the spinal cord and peripheral sites 
of injury (Herrero et al., 1997).  These authors suggest that because of the dual action on both 
COX and LIPOX pathways, ketoprofen has displayed a more potent response in decreasing 
muscle damage.  
 O‟Grady et al. (2000) looked at the systemic administration of diclofenac sodium on 
indices of muscle damage during a 27-day trial with an unaccustomed stepping exercise 
program on day 15.  Looking at CK as an indicator for muscle damage, the researchers 
discovered that post-exercise muscle samples exhibited less muscle tissue damage and 
suppression of subsequent inflammation in the treatment group than the control group.  Also 
using muscle histological evidence for support of diclofenac sodium, researchers found only 
one abnormal muscle sample in the treatment group, compared to 11 in the placebo group.  
Abnormal and normal were defined as presence of edema, inflammation, or necrotic fibers. 
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  Calcium-Channel Blockers 
 The exact mechanism for why intracellular levels of calcium are elevated within 
muscle cells following a contraction-induced injury is uncertain, but some proposed 
hypotheses have been studied.  There could be a loss of sarcoplasmic reticulum membrane 
integrity, a possible rupture of the sarcolemmal membrane, opening of stretch-responsive 
channels, or alterations in triad and t-tubule orientation resulting in calcium entry via voltage-
sensitive channels. Duan et al. (1990) showed that after downhill walking there was 
disruption of the sarcolemma that allows for increased intracellular calcium concentrations 
that could contribute to the progression of muscle damage.  This study provided evidence 
that, through the administration of a calcium-channel blocker, there was a reduction in the 
severity of z-band streaming, indicating less muscle cell damage.  Beaton et al. (2002) 
provided parallel results in that a calcium-channel blocker had no effect at reducing CK 
activity or slowing the inflammatory response but rather displayed a reduction in z-band 
streaming and desmin disruption, which provides evidence of less damage to sarcomeric 
proteins.  These studies provided a basis of understanding that reducing the amount of 
intracellular calcium that results from unaccustomed exercise could have an effect on 
reducing the amount of cellular damage. 
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CHAPTER 3.  METHODS 
  
 Thirty-two male volunteers (24 ± 5 years old, 178.9 ± 6.3 cm tall, 81.5 ± 15.5 kg, and 
a BMI of 25.4 ± 4.5) were recruited for this matched-pairs, double-blind study with subjects 
being matched on initial isometric strength levels.  All were healthy, not currently 
participating in strength training nor having participated in strength training for the past six 
months.  The subjects participated in physical activity, on average, 1-2 days a week for less 
than 30 minutes each session for less than 3 months and maintained an average (self-
reported) fitness level.  Subjects were not currently taking medications or dietary 
supplements known to effect exercise tolerance, immune function, antioxidant status, or 
inflammation, but a daily multivitamin that meets, but does not exceed, the RDA was 
permitted.  Each subject was asked to participate in a resistance training session designed to 
produce moderate muscle soreness.  During the four weeks preceding the trial, participants 
consumed a daily oral dose of either placebo or 500 mg/day of EpiCor taken with breakfast.  
After being adequately matched, subjects were randomly placed into a treatment group. The 
subjects were instructed to avoid exercise for 3 days prior to the resistance training session as 
well as the four days of data collection during the fifth week. 
 On the day of the resistance training session, the subjects reported to the laboratory at 
8 o‟clock in the morning where they completed the visual analogue scale (VAS) for soreness 
(Cook et al., 1997), the Feelings Scale psychological questionnaire, and an illness survey.  
Once the surveys were completed, arm circumference measurements were taken before the 
exercise protocol at a location half way between the top of the shoulder and the tip of the 
elbow in a 90-degree flexion position with the use of a tension tape-measure.  Subjects then 
provided a 10mL blood and a 5mL urine sample prior to any exercise.  Subjects performed a 
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3-repetition isometric maximal strength test prior to the exercise protocol at 110
 o
 of elbow 
flexion, beginning with the dominant hand.  The exercise protocol consisted of performing 
50 maximal eccentric contractions at 30
o
 per second and moved through the range of motion 
of the elbow.  Subjects reported to the laboratory at 24, 48, and 72 hours after completing the 
resistance training to repeat all surveys, 3RM strength tests, and blood and urine sampling.  
During the 72 hours of recovery, subjects were instructed to refrain from exercise and to 
continue to consume the supplement. 
 All blood measures were assessed pre-exercise and at all time-points post-exercise 
that included 4 time-points total.  Clinical biochemical measures included ALT, AST, LDH, 
bilirubin, uric acid, urea, albumin, as well as complete blood count.  Inflammatory measures 
assessed in our laboratory by ELISA or colormetric assay include Il-1 receptor antagonist, 
IL-6, IL-10, CRP, and CK.   
Statistical analysis was performed using 2-way ANOVAs with repeated measures on 
time through the SigmaStat analysis software.  Statistical significance was established using 
a significance level of α=0.05 and was examined for differences both between and within 
groups.  For significant results a Holms-Sidak post-hoc analysis was conducted.  Group 
summary data were presented as mean ± standard deviation.  Researchers remained blind as 
to the actual treatment groups until the entire statistical analysis was completed. 
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CHAPTER 4.  RESULTS 
 
 After the initial analysis, the data were condensed by removing outliers beyond ±2 
standard deviations using the rationale that 95 percent of the data are contained within 2 
standard deviations of the mean in a normal distribution.  In addition to removing the 
outliers, two subjects were removed due to reported symptoms of illness and three subjects 
were removed as a result of reporting insignificant levels of muscle soreness after the 
exercise protocol for the 72 hours after exercise.  VAS soreness data were averaged over the 
four days of data collection, and subjects with mean soreness ± 2 standard deviations were 
removed from the analysis.  Following the removal of the extreme data, the 2-way repeated 
measures ANOVA was again performed. 
 Peak isometric strength results showed a significant time main effect (P<0.001) but 
no statistically significant difference existed between treatment groups (P=0.614) (Table 1).   
 
Table 1.  Means and standard deviations for peak isometric strength for each time point and 
treatment (N·m). 
 Pre 24hr post 48hr post 72hr post 
Overall 68.1 ± 17.5 44.1 ± 14.5 42.9 ± 13.7 47.8 ± 13.1 
EpiCor 70.1 ± 18.1 47.7 ± 15.1 41.2 ± 13.0 47.8 ± 12.2 
Placebo 66.0 ± 17.4 40.8 ± 13.5 44.7 ± 14.6 47.7 ± 14.5 
 
Both groups experienced a similar decrease in peak strength values 24 hours post exercise, 
but the placebo group displayed a quicker, but not significant, start to recovery when 
compared to EpiCor, as this group experienced a continued decrease in strength values for 48 
hours post exercise (Figure 1).   Results at 24, 48, and 72 hours post-exercise all had lower 
peak strength data when compared to baseline (Table 1).  The soreness variable resulted in no 
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significant difference between treatments (P=0.869) and a significant effect for time 
(P<0.001).   
 
 
 
 
Figure 1.  Average dominant arm peak isometric strength for 
each treatment group.
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Figure 2 displays that the EpiCor group demonstrated a greater amount of self-reported 
soreness 24 hours post-exercise when compared to placebo.  The EpiCor group, however, 
displayed a quicker decrease in soreness values when compared to the placebo group 
between 24 and 72 hours post-exercise (Table 2).    
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Table 2.  Means and standard deviations for dominant arm soreness for each time point and 
treatment (cm). 
 Pre 24hr post 48hr post 72hr post 
Overall 0.3 ± 0.4 6.1 ± 1.9 5.0 ± 1.8 3.4 ± 1.6 
EpiCor 0.4±  0.4 6.4 ± 1.7 4.9 ± 2.3 3.2 ± 1.7 
Placebo 0.3 ± 0.4 5.8 ± 2.1 5.1 ± 1.4 3.5 ± 1.7 
 
Figure 2.  Average self-reported soreness for each treatment group.
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Circumference data displayed no significant difference between treatment groups, as both 
treatments experienced similar amounts of swelling (P=0.974) and a statistically significant 
time effect was present (P<0.001) (Table 3).  Post-hoc analysis showed that all time-points 
were significantly higher than pre-exercise measurements (Figure 3). 
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Table 3.  Means and standard deviations of arm circumference for each time point and 
treatment (cm). 
 Pre 24hr post 48hr post 72hr post 
Overall 30.2 ± 2.7 30.8 ± 2.6 30.8 ± 2.8 30.9 ± 2.8 
EpiCor 30.1 ± 1.7 30.8 ± 1.7 30.8 ± 1.9 31.1 ± 1.8 
Placebo 30.4 ± 3.4 30.8 ± 3.3 30.8 ± 3.5 30.7 ± 3.5 
 
 
Figure 3.  Average dominant arm circumference measure for each 
treatment group.
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Creatine kinase results displayed in Figure 4 showed no difference (P=0.738) between 
treatments and a consistent significant difference (P=0.002) between time points 48 and 72 
hours when compared to baseline (Table 4).  The results for LDH paralleled creatine kinase 
with no statistical difference (P=0.825) present between treatment groups as displayed in 
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Figure 5.  There was a significant effect of time evident between 0 and 72 hours (P=0.003) 
(Table 5). 
Figure 4.  Average plasma creatine kinase(CK) for each
treatment group. 
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Table 4.  Mean and standard deviation for creatine kinase (CK) for each time point and 
treatment (IU/mL). 
 Pre 24hr post 48hr post 72hr post 
Overall 83 ± 39 170 ± 71 388 ± 503 869 ± 1568 
EpiCor 90 ± 42 157 ± 65 321 ± 454 833 ± 1306 
Placebo 75 ± 35 184 ± 77 451 ± 554 905 ± 1874 
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Figure 5.  Average plasma LDH values or each treatment group.
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Table 5.  Means and standard deviations for lactate dehydrogenase (LDH) for each time point 
and treatment (IU/mL). 
 Pre 24hr post 48hr post 72hr post 
Overall 163 ± 19 174 ± 25 185 ± 32 195 ± 58 
EpiCor 166 ± 18 176 ± 22 182 ± 31 193 ± 44 
Placebo 161 ± 21 173 ± 28 189 ± 34 198 ± 72 
 
The inflammatory marker IL-1(ra) (Figure 6) showed no significant changes between 
treatment groups or over time, (P=0.783 and 0.526, respectively), with means and standard 
deviations found in Table 6.  IL-6 levels did not significantly change between treatments 
(P=0.570) or over time (P=0.694), but the IL-6 results showed a distinct trend after 24 hours 
post-exercise: placebo showed a continual decrease while EpiCor showed a substantial 
increase by 72 hours post-exercise (Table 7 and Figure 7).  
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Figure 6.  Average IL-1ra concentrations for each 
treatment group.
 
Table 6.  Means and standard deviations for IL-1ra for each time point and treatment 
(mg/dL). 
 Pre 24hr post 48hr post 72hr post 
Overall 0.89 ± 0.34 0.87 ± 0.24 0.82 ± 0.22 0.86 ± 0.25 
EpiCor 0.86 ± 0.32 0.87 ± 0.24 0.84 ± 0.23 0.86 ± 0.30 
Placebo 0.82 ± 0.29 0.86 ± 0.25 0.79 ± 0.20 0.85 ± 0.16 
 
 
Table 7.  Means and standard deviations for IL-6 for each time point and treatment (mg/dL).  
 Pre 24hr post 48hr post 72hr post 
Overall 0.98 ± 0.74 0.86 ± 0.61 0.97 ± 0.67 1.04 ± 0.83 
EpiCor 0.92 ± 0.70 0.85 ± 0.53 1.08 ± 0.58 1.22 ± 0.92 
Placebo 1.05 ± 0.81 0.89 ± 0.72 0.83 ± 0.78 0.67 ± 0.30 
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Figure 7.  Average IL-6 concentrations for each treatment group.
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The anti-inflammatory cytokine IL-10 displayed in Figure 8 provides evidence that no 
significant differences exist between treatments (P=0.285) or between time points (P=0.284) 
(Table 8).  IL-10 does show a consistent decrease in the EpiCor group values and an increase 
in placebo values through 48 hours post-exercise.  These trends, however, are not significant.  
CRP results exhibited similar levels of non-significance for time (P=0.801) and between 
groups (P=0.814) (Table 9) and can be viewed in Figure 9. 
 
Table 8.  Means and standard deviations for IL-10 for each time point and treatment (pg/mL). 
 Pre 24hr post 48hr post 72hr post 
Overall 2.13 ± 1.43 2.24 ± 1.43 2.02 ± 1.92 1.83 ± 1.30 
EpiCor 2.01 ± 1.05 1.90 ± 0.88 1.49 ± 0.80 1.81 ± 1.19 
Placebo 2.27 ± 1.81 2.63 ± 1.85 2.65 ± 2.58 1.92 ± 1.42 
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Figure 8.  Average IL-10 concentrations for each 
treatment group.
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Table 9.  Means and standard deviations for C-reactive protein (CRP) for each time point and 
treatment (ng/mL). 
 Pre 24hr post 48hr post 72hr post 
Overall 10.40 ± 10.29 12.18 ± 11.25 12.78 ± 13.62 12.41 ± 12.69 
EpiCor 10.04 ± 8.21 13.03 ± 11.16 14.08 ± 12.72 14.96 ± 13.67 
Placebo 10.79 ± 12.42 11.22 ± 11.69 11.28 ± 14.93 9.51 ± 11.25 
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Figure 9.  Average CRP concentration for each treatment group 
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CHAPTER 5.  DISCUSSION 
 
 The results of the study show that no statistically significant differences were present 
between EpiCor and placebo treatments for any dependent variable.  The final statistical 
analysis resulted in the removal of two subjects who experienced symptoms of illness (fever, 
cough, sore throat, etc.) and three subjects who did not report significant soreness during the 
72 hours post-exercise.  Therefore, a sample size of 27, 14 subjects in the EpiCor group and 
13 subjects in the placebo group, was used in the analysis. 
 Data from the current study are consistent with previous research and indicate that 
muscle damage did occur from the specific eccentric exercise protocol of the elbow flexors.  
Isometric strength values showed a maximum decrease of 41.3 and 38.1% for the EpiCor and 
placebo groups, respectively, which agrees with Jones et al., 1987, Howell et al., 1993, and 
Gibala et al., 1995.  Gibala and colleagues provided muscle biopsy evidence to support their 
findings that up to 80% fiber disruption was still present after 48 hours of recovery.  While 
we did not perform muscle biopsies, it could be suggested that similar damage occurred from 
a more taxing exercise protocol (64 repetitions at 80% of one-repetition max in Gibala‟s 
study compared to 50 repetitions at maximum intensity in the present study) in addition to 
continued decreases in strength at 48 hours post-exercise.  Peak isometric strength values 
were still diminished between 27.7 and 31.8% below baseline after 72 hours, indicating that 
EpiCor did not aid in the recovery of muscle strength (Figure 1, Table 10).  Howell et al. 
(1993) still reported a 30% decrease in strength 10 days post-eccentric exercise of the elbow 
flexors which confirms the findings of the present study.     
Another indicator of muscle damage in the present study is muscle soreness, which 
had a significant effect of time (P<0.001) with significantly different levels of soreness at 
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each time point.  Figure 2 displays that peak soreness occurred at 24 hours post-exercise and 
never returned to baseline.  Armstrong (1991) and Clarkson et al. (1992) both provided 
results that peak soreness occurs between 48-72 hours post-exercise, which could suggest 
that EpiCor elicited a faster recovery in muscle soreness after exercise; however, there were 
no differences between treatments (P<0.87), which provides evidence that EpiCor did not 
significantly reduce muscle soreness.   
 Other indicators of muscle damage, including CK and LDH, both have a significant 
effect of time, and their respective figures (4, 5) show that subjects still had elevated levels of 
both markers after 72 hours of recovery.  These continual levels, although not significantly 
different, do demonstrate both that a significant amount of muscle damage did occur and the 
EpiCor supplementation did not help to reduce the amount of muscle damage.  Additionally, 
the evidence demonstrates that EpiCor did not enhance the rate or amount of recovery, as 
demonstrated by both the isometric strength and soreness levels.  
 Measures of inflammation showed no significant difference between placebo and 
EpiCor-supplemented groups, but some trends were present.  CRP data displayed a near-
linearly increasing trend during the entire 72 hour time period post-exercise while the 
placebo group demonstrated a steady decline in CRP levels after 24 hours post-exercise 
(Figure 9).  A near-significant treatment versus time effect was present (P=0.088), and post-
hoc analysis revealed a similar significance level between 0 and 72 hours post-exercise.  
Generally, research indicates that CRP levels after eccentric exercise are still mixed as 
neither Milias et al. (2005) nor Nosaka & Clarkson (1996) reported significant increases in 
CRP while Malm et al. (2000) and Paulsen et al. (2005) demonstrated an increase in CRP 
levels after eccentric exercise.  The first group of researchers utilized elbow flexors for 24-36 
42 
 
maximal eccentric repetitions whereas the second group of researchers utilized leg extensors 
for 30 minutes of eccentric cycling and 300 maximal eccentric contractions.  These brief 
descriptions highlight an aerobic component in the latter studies and suggest that CRP release 
is related to muscle damage elicited by eccentric endurance exercise.  Additionally, the 
difference in muscle mass or duration of maximal eccentric exercise could have an impact as 
damaging a greater amount of muscle fibers for a greater amount of time could lead to a 
greater CRP release. 
 The response of IL-10 also showed a trend (P=0.109) throughout the 72-hour 
recovery time period as subjects with the EpiCor supplement displayed lower levels of IL-10 
when compared to subjects with the placebo (Figure 8).  The control group saw an increase 
during the first 48 hours post-exercise whereas the treatment group saw a decrease during the 
first 48 hours post exercise.  This result, although not significant, is similar to results as 
shown by Smith et al. (2000) and Silva et al. (2008).  Silva displayed results for an increased 
IL-10 response in all subjects 96 hours post eccentric exercise of the elbow flexors while 
Smith et al. showed significantly elevated IL-10 levels 72-144 hours post-exercise using 
hamstrings and pectoralis muscle groups.  Both Smith and Silva utilized a greater amount of 
muscle mass than the present study, which could result in increased inflammatory responses 
from a greater amount of muscle damage elicited and subsequent increased anti-
inflammatory response.  With the hypothesized anti-inflammatory effects of EpiCor (Jensen 
et al., 2007, 2008), the treatment group should have continually elevated IL-10 levels that 
indicate an increase in the anti-inflammatory response that would combat and lower the pro-
inflammatory response.  Previous unpublished research with the EpiCor supplement provided 
results that, immediately post-exercise, IL-10 levels increased and returned to normal levels 
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at 24 hours post-exercise, which suggests a greater anti-inflammatory response mediated by 
the EpiCor supplement.  This study utilized intense cycling for two five-day trial periods 
with a two-day rest period between weeks.  Each trial period included both aerobic and 
anaerobic cycling for >60 minutes each day that ended with a 90-minute cycling endurance 
exercise.  Comparing the protocols between the studies demonstrates that the endurance 
exercise elicited a greater anti-inflammatory response compared to the muscular strength 
exercise. 
 Results for IL-1ra showed that no statistically significant differences existed between 
the EpiCor and placebo groups, which do not support EpiCor as having anti-inflammatory 
capabilities.  Il-1ra has been shown as having anti-inflammatory capabilities with pro-
inflammatory release patterns as this cytokine is released in conjunction with IL-1, a pro-
inflammatory cytokine, to keep the inflammation under control.  Nosaka and Clarkson (1996) 
provided evidence of no increase in IL-1ra levels after eccentric exercise in the elbow 
flexors, but previous EpiCor research as described above in addition to Ostrowski et al. 
(1999) demonstrated a significant elevation in IL-1ra post-exercise, 24 hours post-, and 
immediately post-exercise, respectively.  A distinct difference in exercise protocol exists 
among these studies that show contradicting findings, as the latter two studies utilized intense 
endurance exercise in the form of a 2-week cycling period and runners in the 1997 
Copenhagen Marathon.   
 The inflammatory measure of IL-6 resulted in no significant differences between the 
EpiCor and placebo groups during the post-exercise time period.  Previous research shows 
that IL-6 is a regulatory cytokine with both anti- and pro-inflammatory characteristics 
(Bruunsgaard et al., 1997).  Substantial evidence has been provided that IL-6 is a sensitive 
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marker of inflammation and is one of the first cytokines released after damage occurs.  For 
example, MacIntyre et al. (2001), Willoughby et al. (2003), and Paulsen et al. (2005) showed 
that a peak saturation of IL-6 occurred approximately six hours after exercise and that early 
increases in IL-6 predicted a component of delayed onset muscle soreness.  The present study 
did show a significant time effect of delayed onset muscle soreness (Figure 7) but no 
significant change in IL-6.  Although IL-6 had no measurable change, it cannot be ruled out 
that changes may have occurred since no blood sample was taken before 24 hours.     
 Limitations did exist to the present study and include the timing of blood measuring, 
physical conditioning of subjects, and exercise type.  Many researchers have indicated that 
statistically significant changes occur prior to 24 hours post-eccentric exercise (MacIntyre et 
al, 2001, Willoughby et al., 2003, Tomiya et al., 2004).  Adding another time-point prior to 
24 hours post-exercise or measuring closer than 24 hours could provide the additional data 
needed to demonstrate significance for our results.  Another limitation of the study was that 
some subjects had maintained a constant exercise routine prior to the study that could have 
enhanced the internal recovery process after exercise-induced damage.  Untrained individuals 
are more likely to experience more muscle damage and a greater inflammatory response than 
individuals with some recent exercise training history.  Had the subjects only been drawn 
from individuals with no previous exercise history in the past 6 months, instead of non-
weightlifting experience, there may have been more exercise-induced muscle damage and, 
therefore, greater stimulus for an inflammatory response.  Finally, there were some subjects 
who self-reported very little soreness post-exercise.  If the exercise protocol were enhanced 
with more repetitions or included more muscle mass through other eccentric movements to 
help create soreness, the results of the study could be significant.   
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  Overall, the results of this study show that no significant differences were present 
between the EpiCor and placebo treatment groups in reducing muscle damage and alleviating 
muscle soreness.  A few trends were present that suggests differences may exist between 
treatment groups for inflammatory markers; however, these results continue to warrant future 
research with yeast-metabolites in the aid of reducing muscle damage and soreness after 
unaccustomed eccentric exercise. A suggestion for future research includes using subjects 
with no recent exercise history.  This present study used subjects with no recent weight-
lifting history (>6 months), and any adaptations from consistent aerobic exercise could aid in 
the clearance of inflammatory or muscle damage markers faster than normal.  
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Table 10.  Means and standard deviations of isometric strength for each time point and 
treatment (Nm). 
 Pre 24hr post 48hr post 72hr post 
Overall 68.0 ± 17.6 43.1 ± 14.2 43.8 ± 14.0 47.5 ± 14.0 
EpiCor 68.8 ± 17.3 45.6 ± 15.4 42.8 ± 14.8 46.7 ± 11.8 
Placebo 67.1 ± 18.4 40.7 ± 13.0 44.7 ± 13.5 48.4 ± 16.2 
 
Table 11.  Means and standard deviations of soreness for each time point and treatment (cm) 
 Pre 24hr post 48hr post 72hr post 
Overall 0.41 ± 0.54 5.55 ± 2.26 4.80 ± 2.47 3.29 ± 2.25 
EpiCor 0.53 ± 0.61 5.64 ± 2.33 4.62 ± 2.75 3.21 ± 2.45 
Placebo 0.28 ± 0.45 5.46 ± 2.27 4.99 ± 2.23 3.38 ± 2.10 
 
Table 12.  Means and standard deviations of circumference for each time point and treatment. 
(cm) 
 Pre 24hr post 48hr post 72hr post 
Overall 30.4 ± 3.8 31.0 ± 3.7 30.9 ± 3.9 31.0 ± 3.8 
EpiCor 30.5 ± 3.9 31.1 ± 3.8 31.2 ± 4.1 31.3 ± 3.8 
Placebo 30.4 ± 3.9 30.8 ± 3.7 30.7 ± 3.9 30.7 ± 3.9 
 
Table 13.  Mean and standard deviations of CK for each time point for each treatment group. 
(mg/dL) 
 Pre 24hr post 48hr post 72hr post 
Overall 96 ± 72 184 ± 127 523 ± 861 1310 ± 3472 
EpiCor 102 ± 64 178 ± 133 655 ± 1109 1855 ± 4624 
Placebo 91 ± 82 189 ± 125 388  ± 514 765 ± 1704 
 
Table 14.  Means and standard deviations of LDH for each time point for each treatment 
group (mg/dL). 
 Pre 24hr post 48hr post 72hr post 
Overall 165 ± 21 175 ± 28 192 ± 46 209 ± 115 
EpiCor 167 ± 20 173 ± 23 186 ± 42 224 ± 150 
Placebo 163 ± 22 177 ± 33 198 ± 49 194 ± 65 
 
Table 15.  Means and standard deviations of IL-1ra for each treatment and time point 
(mg/dL). 
 Pre 24hr post 48hr post 72hr post 
Overall 0.94 ± 0.44 1.07 ± 0.66 1.06 ± 0.85 1.03 ± 0.83 
EpiCor 0.95 ± 0.40 1.05 ± 0.61 0.90 ± 0.28 0.89 ± 0.31 
Placebo 0.93 ± 0.49 1.09 ± 0.73 1.22 ± 1.17 1.16 ± 1.13 
 
Table 16.  Means and standard deviations of IL-6 for each treatment and time point (mg/dL). 
 Pre 24hr post 48hr post 72hr post 
Overall 1.64 ± 2.13 2.37 ± 4.56 1.79 ± 2.78 1.80 ± 2.19 
59 
 
EpiCor 1.00 ± 0.70 2.19 ± 5.06 1.08 ± 0.55 1.22 ± 0.92 
Placebo 2.27 ± 2.84 2.55 ± 4.15 2.51 ± 3.82 2.38 ± 2.89 
 
Table 17.  Means and standard deviations of IL-10 for each treatment and time point 
(pg/mL). 
 Pre 24hr post 48hr post 72hr post 
Overall 3.02 ± 4.77 3.15 ± 4.87 2.93 ± 4.84 2.57 ± 4.69 
EpiCor 1.96 ± 0.99 2.02 ± 1.09 1.59 ± 0.85 1.56 ± 1.26 
Placebo 4.08 ± 6.61 4.28 ± 6.72 4.26 ± 6.63 6.45 ± 3.57 
 
Table 18.  Means and standard deviations of CRP for each treatment and time point (ng/mL). 
 Pre 24hr post 48hr post 72hr post 
Overall 12.76 ± 16.64 15.32 ± 16.59 16.73 ± 20.69 16.35 ± 20.10 
EpiCor 10.04 ± 8.21 13.03 ± 11.16 14.08 ± 12.72 14.96 ± 13.67 
Placebo 15.43 ± 22.12 17.61 ± 20.81 19.38 ± 26.61 17.74 ± 25.38 
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Muscle Soreness Survey
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